The case raises a Constitutional question about the power of a president to impound funds that were authorized by Congress, ...

A Lim Kim made enough birdies in an up-and-down second round to maintain a cushion between herself and top-ranked Nelly Korda at the Hilton Grand Vacations Tournament of Champions, the LGPA Tour ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...

After leading Japan’s largest drugmaker for 11 years, Takeda CEO Christophe Weber plans to step down in June of 2026. He will ...

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...

I am excited to guide Takeda through the next phase, together with our exceptional and talented people, while staying true to ...

Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025Management ViewChristophe Weber, CEO, announced his retirement ...

York Space Systems (York) said on Jan. 29 it had expanded its satellite platform portfolio, adding the M-CLASS, which is now its largest platform. The M-CLASS builds upon York’s existing […] ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...